Singularity Securities Settlement
Each class member receives a pro rata share of the net settlement fund based on their recognized claim amount compared to total recognized claims of all claimants.
This settlement is closed to new claims — the deadline was January 16, 2026. You can still see what it was about and follow the case in court below. Looking for money you can still claim? Browse open settlements →
What happened
Defendants allegedly misled shareholders about the benefits and value of various transactions, joint ventures, and business plans relating to Singularity's transformation from a global logistics company to a cryptocurrency mining and hardware development business. The defendants deny all allegations of wrongdoing.
Do you qualify?
Anyone who purchased or otherwise acquired Singularity Future Technology Ltd. securities between February 2, 2021 and February 24, 2023. Excluded are defendants, officers and directors of Singularity, and their immediate family members.
How to file
File a timely and valid Claim Form with the Claims Administrator by January 16, 2026. The Claim Form will be made available by the Court-appointed Claims Administrator and contains information needed to determine your distribution amount. Contact the Claims Administrator at the provided address, phone number, or email if you do not receive a form.
Common questions
- How much does the Singularity Securities Settlement pay?
- Estimated payout: Each class member receives a pro rata share of the net settlement fund based on their recognized claim amount compared to total recognized claims of all claimants.. The total settlement fund is $8.5M. Actual amounts depend on how many valid claims are filed — most settlements divide a fixed fund pro rata, so a higher claim rate means a smaller individual check. An "up to" figure is a cap, not a guarantee.
- What is the claim deadline for the Singularity Securities Settlement?
- This settlement is closed to new claims — the deadline was January 16, 2026. Once a claim deadline passes you generally forfeit your share, even if you qualified.
- Do I need proof of purchase for the Singularity Securities Settlement?
- Yes. This settlement asks for documentation supporting your claim — a receipt, an account record, or the notice you were sent. Check the official settlement website for exactly which documents are accepted.
- Is the Singularity Securities Settlement notice real, or a scam?
- Claims Administrator (address: PO Box 25191, Santa Ana, CA 92799) is the settlement administrator for this case. Claims are filed at singularitysecuritiessettlement.com. Filing a class action claim is always free — no legitimate settlement charges you to claim, and no administrator will ask for payment, a gift card, or your full Social Security number by email or text. If a notice asks for any of those, it is not from the administrator. When in doubt, ignore the link you were sent and go to the official settlement website directly.
- When will payments from the Singularity Securities Settlement be sent?
- Class action payouts typically take 12 to 24 months after the claim deadline, and longer if the settlement is appealed. The final approval hearing for this case is set for March 9, 2026; no payments can be issued before a settlement receives final approval.
New to class actions?
This summary was generated from public settlement documents and may contain errors. Confirm eligibility, deadlines, and payment terms on the official settlement website before filing. ClaimWatch is not a law firm and this is not legal advice. Filing a claim is free.
More securities settlements
View all →Revance Securities Settlement
Revance Therapeutics and its executives made material misrepresentations and omissions regarding the company's relationship with Teoxane SA and the tender offer and merger transaction with Crown Laboratories, Inc., allegedly violating federal securities laws. Defendants deny any wrongdoing or liability.
Not yet determinable; depends on number of valid claims submitted
Biogen Securities Litigation Settlement
Biogen Inc. investors have settled a securities litigation case for $18.9 million in cash. The settlement resolves claims related to purchases of Biogen common stock during the specified class period.
NJ Bureau of Securities Settlement with Credit Suisse
Credit Suisse allegedly violated New Jersey Securities Law by making materially false and misleading statements regarding RMBS trust certificates and engaging in fraudulent practices. On October 24, 2022, the court entered a consent order requiring Credit Suisse to pay $300 million in restitution to investors. Credit Suisse neither admitted nor denied the allegations.
Stitch Fix Securities Litigation Settlement
Stitch Fix, Inc. is settling a securities class action lawsuit without admitting wrongdoing. The Lead Plaintiffs alleged that Stitch Fix issued misleading statements about its business, and shareholders who purchased the stock during the class period suffered damages as a result.